Minocycline inhibits in vitro invasion and experimental pulmonary metastasis of mouse renal adenocarcinoma.
Masumori
N
N
Department of Urology, Sapporo Medical University School of Medicine, Japan.
Miyao
N
N
Takahashi
A
A
Sasamura
H
H
Kitamura
H
H
Tsukamoto
T
T
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000201:enzymology / Q000556:secondary*; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors; D016222:Fibroblast Growth Factor 2 / Q000037:antagonists & inhibitors; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000556:secondary*; D008222:Lymphokines / Q000037:antagonists & inhibitors; D061965:Matrix Metalloproteinase Inhibitors; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D051379:Mice; D008911:Minocycline / Q000494:pharmacology* / Q000627:therapeutic use; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D011480:Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D018709:Statistics, Nonparametric; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors